Search Results 161-170 of 2477 for 2024embarking
This is a single arm, open-label, multi-center, phase 1/2 study, to determine the safety and efficacy of KTE-X19, an autologous anti-CD19 chimeric antigen ...
10 patients receive the ultimate gift in a single day at Mayo Clinic featured image · a microscopic slide of glioblastoma brain cancer cells.
About this study. The purpose of this study is to identify a dose of mangaciclanol for the Phase 3 part of the study that has an overall diagnostic ...
Mayo Clinic Comprehensive Cancer Center researchers spent 2024 mining patient data, leveraging artificial intelligence and conducting clinical trials to ...
Patients with recurrent, platinum-sensitive high-grade serous ovarian cancer (HGSOC) including fallopian tube and primary peritoneal cancer expressing high ...
ROCHESTER, Minn. — Mayo Clinic research identified a powerful new way to improve the prediction of a patient's long-term cardiovascular disease risk by ...
This study will evaluate the safety, efficacy, and pharmacokinetics of atezolizumab in combination with bevacizumab, bevacizumab + oxaliplatin, leucovorin and 5 ...
If you've been bit by a stomach bug lately, you're not alone. Noroviruses are usually more widespread in the fall and winter, but you can get[...].
Enzyme inhibitors, such as ibrutinib and ixazomib citrate, may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.